文献速递临床试验与 GCP真实世界研究与卫生经济

个体就业支持对酒精和药物依赖患者就业效果的多中心确定性随机对照试验方案

Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence.
PubMed 文献 · Trials · 2020-02-11

本研究为七中心、实用性、两臂平行组、优效性随机对照试验,旨在验证个体就业支持(IPS)对酒精使用障碍、阿片使用障碍及其他药物使用障碍患者竞争性就业的效果。参与者随机接受常规治疗加标准就业支持或常规治疗加IPS(9个月加最多4个月在职支持),主要结局为18个月随访期间竞争性就业状态,目标样本832例,注册号ISRCTN24159790。

要点

  • IPS是首个在酒精和药物依赖人群中开展的大规模多中心确定性优效性随机对照试验。
  • 干预为常规治疗加IPS(9个月)及最多4个月在职支持,对照为常规治疗加标准就业支持。
  • 主要结局为18个月随访期间竞争性就业(至少1天7小时),通过链接国家税务和福利数据库确定。

核心结论

  • 该研究将确定IPS对酒精使用障碍、阿片使用障碍及其他药物使用障碍患者是否有效。

研究设计与样本

  • 七中心、实用性、两臂平行组、优效性随机对照试验,纳入至少失业或经济不活跃6个月、希望获得开放就业市场工作并正在接受社区常规治疗(TAU)的成年酒精或药物依赖患者,按1:1随机分配至TAU加标准就业支持或TAU加IPS(9个月加最多4个月在职支持),并进行现实主义过程评估。

主要发现

  • 原文未报告研究结果。

关键数值与推荐

  • 主要结局为18个月随访期间竞争性就业(至少1天7小时),通过患者层面试验数据链接国家税务和州福利数据库确定。
  • 基于荟萃分析,假设实验干预组目标差异为18%,双侧5%显著性水平,需至少832例参与者以达到90%把握度(针对预注册的混合效应多变量逻辑回归模型)。
  • 缺失结局数据将采用最大似然多重插补法处理。
  • 六个职业次要结局:18个月随访期间竞争性就业总时间(及相应国民保险缴费和税款)、从随机化到首次竞争性就业的时间、竞争性工作录用次数、工作任期(最长竞争性就业持续时间)、持续就业(单一录用任期至少13周)、求职自我效能。
  • 将利用主要结局和次要职业结局分别进行主要成本效益分析和次要成本效果分析,包括成瘾治疗及社会和健康结局及其相关参考成本。

临床怎么用

  • 若证实有效,研究结果将对酒精和药物依赖患者的就业服务提供产生重要影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unemployment is highly prevalent in populations with alcohol and drug dependence and the employment support offered in addiction-treatment programmes is ineffective. Individual Placement and Support (IPS) is an evidence-based intervention for competitive employment. IPS has been extensively studied in severe mental illness and physical disabilities, but there have been no formal randomised controlled trials (RCTs) in alcohol and drug dependence. The Individual Placement and Support for Alcohol and Drug Dependence (IPS-AD) study should determine whether IPS for patients with alcohol use disorder (AUD), opioid use disorder (OUD) and other drug use disorder is effective. DESIGN/METHODS: The IPS-AD study is a seven-site, pragmatic, two-arm, parallel-group, superiority RCT. IPS-AD includes a realist process evaluation. Eligible patients (adult, unemployed or economically inactive for at least 6 months and wishing to obtain open job market employment and enrolled in ongoing community treatment-as-usual (TAU; the control condition) in England for AUD, OUD and other drug use disorders) will be randomised (1:1) to receive TAU and any standard employment support, or TAU plus IPS (the experimental condition) for 9 months with up to 4 months of in-work support. The primary outcome measure will be competitive employment status (at least 1 day (7 h)) during an 18-month follow-up, determined by patient-level, trial-data-linkage with national tax and state benefit databases. From meta-analysis, an 18% target difference on this measure of vocational effectiveness (for the experimental intervention) and a two-sided 5% level of statistical significance, will require a minimum target sample of 832 participants to achieve 90% power for a pre-registered, mixed-effects, multi-variable logistic regression model. A maximum-likelihood multiple-imputation approach will manage missing outcome data. IPS-AD has six vocational secondary outcome measures during the 18-month follow-up: (1) total time in competitive employment (and corresponding National Insurance contributions and tax paid); (2) time from randomisation to first competitive employment; (3) number of competitive job appointments; (4) job tenure (length of longest held competitive employment); (5) sustained employment (tenure in a single appointment for at least 13 weeks); and (6) job search self-efficacy. A primary cost-benefit analysis and a secondary cost-effectiveness analysis will be done using the primary outcome and secondary vocational outcomes, respectively and will include addiction treatment and social and health outcomes and their associated reference costs. The process evaluation will address IPS implementation and delivery. DISCUSSION: The IPS-AD study is the first large-scale, multi-site, definitive, superiority RCT of IPS for people with alcohol and drug dependence. Findings from the study will have substantial implications for service delivery. TRIAL REGISTRATION: ISRCTN Registry, ID: ISRCTN24159790. Registered on 1 February 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Marsden J, Anders P, Clark H, et al. Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence. Trials. 2020. PMID: 32046765. doi:10.1186/s13063-020-4099-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。